C. Augello

发表

Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

V. Adamo, S. Corsale, V. Agnese, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

MGMT-Methylated Alleles Are Distributed Heterogeneously Within Glioma Samples Irrespective of IDH Status and Chromosome 10q Deletion

M. Caroli, C. Augello, S. Bosari, 2016, Journal of neuropathology and experimental neurology.

Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia

C. Augello, E. Berti, U. Gianelli, 2017, Histopathology.

A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer

A. Russo, S. Corsale, V. Agnese, 2006, Breast Cancer Research and Treatment.

Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.

C. Augello, C. Brambilla, S. Bosari, 2015, Leukemia research.

Molecular analyses in the diagnosis of myeloproliferative neoplasm-related splanchnic vein thrombosis

C. Augello, A. Cortelezzi, U. Gianelli, 2015, Annals of Hematology.

Recurrent NAB2–STAT6 gene fusions and oestrogen receptor‐α expression in pulmonary adenofibromas

A. Terrasi, C. Augello, S. Bosari, 2017, Histopathology.

Expression of C19MC miRNAs in HCC associates with stem-cell features and the cancer-testis genes signature.

A. Terrasi, C. Augello, V. Vaira, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

miR-494-3p is a novel tumor driver of lung carcinogenesis

P. Pelicci, C. Augello, V. Vaira, 2016, Oncotarget.

Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

S. Corsale, V. Agnese, S. Cascio, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

TP53 and p16INK4A, but not H‐KI‐Ras, are involved in tumorigenesis and progression of pleomorphic adenomas

A. Russo, S. Corsale, V. Agnese, 2006, Journal of cellular physiology.

Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

G. Altavilla, V. Adamo, A. Russo, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Epigenetic effects of chromatin remodeling agents on organotypic cultures.

C. Augello, S. Bosari, M. Miozzo, 2016, Epigenomics.

miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression

C. Augello, V. Vaira, S. Bosari, 2011, Oncogene.

BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses

A. Giordano, A. Russo, S. Corsale, 2007, Breast Cancer Research and Treatment.

Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

Kylie L. Gorringe, S. Loi, S. Lakhani, 2017, Modern Pathology.

Quantitative DNA methylation analysis improves epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome

C. Augello, F. Lalatta, A. Selicorni, 2013, Epigenetics.

MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma

M. Roncalli, C. Augello, V. Vaira, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma

G. Torzilli, M. Roncalli, C. Augello, 2009, BMC Cancer.

PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis.

C. Augello, S. Bosari, A. Cortelezzi, 2015, Leukemia research.

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

C. Augello, U. Gianelli, I. Cortinovis, 2017, Modern Pathology.

CD18 promoter methylation is associated with a higher risk of thrombotic complications in primary myelofibrosis

A. Terrasi, C. Augello, I. Martinelli, 2016, Annals of Hematology.

4338954792152307 revised-2 Inhibitors of Apoptosis Proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma Authors:

G. Torzilli, M. Roncalli, C. Augello, 2009 .

Transient elastography spleen stiffness measurements in primary myelofibrosis patients: a pilot study in a single centre

D. Consonni, C. Augello, S. Bosari, 2015, British journal of haematology.

4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily).

A. Russo, V. Agnese, S. Cascio, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma

L. Baldini, C. Augello, V. Vaira, 2014, Journal of Clinical Pathology.

MicroRNA‐425‐3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma

R. Labianca, A. Santoro, M. Roncalli, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study.

V. Adamo, S. Corsale, V. Agnese, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Ductal lavage: a way of carefully tracing the breast-secreting duct

A. Giordano, A. Russo, V. Agnese, 2006 .